Skip to main content
Premium Trial:

Request an Annual Quote

OriGene and Tanox Establish Research Collaboration

NEW YORK, Oct. 8 (GenomeWeb News) -- OriGene Technologies of Rockville, Md., and Tanox of Houston today announced a research collaboration for the functional study of 2,000 full-length cDNA clones encoding membrane-bound proteins.

Financial details of the deal were not disclosed.

Tanox, which develops monoclonal antibodies and targets diseases of the human immune system, reserves rights for therapeutic applications identified through the collaboration while OriGene retains rights for research and diagnostic reagent development, the companies said in a statement.

OriGene Technologies has utilized high-throughput cloning and expression profiling to isolate and catalog a searchable gene bank of 20,000 full-length human cDNA clones suitable for transfection and direct in vitro expression.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.